Sarepta Therapeutics, Inc 10-Q for FY2024 Q3
Sarepta Therapeutics, Inc. (SRPT)
10-Q
2024-11-06
For: 2024-09-30
View Original
Added on
April 11, 2026
About this 10-Q
Sarepta Therapeutics, Inc filed this 10-Q on November 6, 2024, covering the quarter ended September 30, 2024 (FY2024 Q3).
Headline figures
Quarter ended September 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $467.17M
- up 40.8% from $331.82M a year earlier
- Net income
- $33.61M
- compared with a net loss of $40.94M a year earlier
- Diluted EPS
- $0.34
- compared with -$0.46 a year earlier